tiprankstipranks
Trending News
More News >
Modern Dental Group Limited (HK:3600)
:3600
Advertisement

Modern Dental Group Limited (3600) AI Stock Analysis

Compare
5 Followers

Top Page

HK:3600

Modern Dental Group Limited

(3600)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
HK$4.50
▼(-15.73% Downside)
Modern Dental Group's strong financial performance and reasonable valuation are the primary drivers of its stock score. The absence of recent cash flow data is a concern, but the company's solid revenue growth and profitability provide a stable foundation. Technical indicators show moderate strength, supporting a positive outlook.

Modern Dental Group Limited (3600) vs. iShares MSCI Hong Kong ETF (EWH)

Modern Dental Group Limited Business Overview & Revenue Model

Company DescriptionModern Dental Group Limited (3600) is a leading dental product and service provider, focusing on the manufacture and distribution of dental prosthetics, equipment, and consumables. The company operates primarily in the dental healthcare sector, catering to both dental professionals and patients. With a commitment to innovation and quality, Modern Dental Group offers a range of products including crowns, bridges, dentures, and orthodontic devices, complemented by a suite of laboratory services designed to support dental practices worldwide.
How the Company Makes MoneyModern Dental Group Limited generates revenue through multiple streams, primarily from the sale of dental prosthetics and related products to dental practices and healthcare providers. The company operates a direct sales model, supplying high-quality dental products and equipment, which accounts for a significant portion of its income. Additionally, it earns revenue through laboratory services, offering custom solutions and products tailored to specific client needs. The company may also engage in partnerships with dental clinics and healthcare organizations, enhancing its market reach and facilitating bulk sales. Furthermore, Modern Dental Group benefits from ongoing relationships with suppliers and distributors, which can lead to favorable pricing and increased sales volume, ultimately contributing to its overall earnings.

Modern Dental Group Limited Financial Statement Overview

Summary
Modern Dental Group shows strong financial performance with robust revenue growth and profitability. The income statement is solid, but the absence of recent cash flow data is a concern that needs addressing to ensure liquidity.
Income Statement
85
Very Positive
Modern Dental Group has demonstrated a strong income statement performance with a consistent increase in total revenue over recent years. The company reported a gross profit margin of approximately 53.5% for the most recent period, and the net profit margin stands at around 12.1%. Both EBIT and EBITDA margins are solid at 15.9% and 19.8%, respectively. The revenue growth rate from 2023 to 2024 was about 6.06%, indicating a positive growth trajectory. Overall, the income statement reflects strong profitability and growth, though there is room for improvement in EBIT consistency.
Balance Sheet
78
Positive
The balance sheet of Modern Dental Group shows a stable financial position with a debt-to-equity ratio of approximately 0.34, indicating moderate leverage. The return on equity (ROE) for the latest period is about 15.0%, which is robust and demonstrates effective management of equity. The equity ratio is a strong 66.7%, highlighting a solid equity base relative to assets. While the company's leverage is under control, continuous monitoring is advised to maintain this stability.
Cash Flow
72
Positive
The cash flow analysis for Modern Dental Group reveals some challenges, particularly with the reporting of operating cash flow and free cash flow being zero for the most recent period. Historically, the company has shown positive free cash flow growth, and the operating cash flow to net income ratio was healthy in previous years. However, the lack of cash flow data for the latest period raises concerns about cash management, which needs addressing to ensure liquidity and operational efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.50B3.36B3.17B2.83B2.96B2.19B
Gross Profit1.89B1.80B1.70B1.38B1.55B1.09B
EBITDA731.58M719.12M696.64M464.09M627.01M295.21M
Net Income478.00M408.00M404.10M220.46M360.82M107.76M
Balance Sheet
Total Assets4.40B4.07B3.95B3.54B3.66B3.67B
Cash, Cash Equivalents and Short-Term Investments595.26M816.83M697.69M447.72M638.00M746.71M
Total Debt768.60M924.22M852.20M788.19M833.09M1.03B
Total Liabilities1.33B1.35B1.31B1.21B1.30B1.41B
Stockholders Equity2.99B2.72B2.63B2.32B2.35B2.25B
Cash Flow
Free Cash Flow487.63M379.37M416.04M53.36M369.27M303.87M
Operating Cash Flow579.73M521.19M575.76M238.72M510.72M376.32M
Investing Cash Flow-298.13M-145.47M-154.96M-227.55M-142.65M-47.32M
Financing Cash Flow-398.21M-227.70M-173.64M-201.79M-452.12M-32.95M

Modern Dental Group Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5.34
Price Trends
50DMA
5.35
Negative
100DMA
4.87
Positive
200DMA
4.38
Positive
Market Momentum
MACD
0.03
Negative
RSI
49.87
Neutral
STOCH
70.54
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3600, the sentiment is Positive. The current price of 5.34 is above the 20-day moving average (MA) of 5.33, below the 50-day MA of 5.35, and above the 200-day MA of 4.38, indicating a neutral trend. The MACD of 0.03 indicates Negative momentum. The RSI at 49.87 is Neutral, neither overbought nor oversold. The STOCH value of 70.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:3600.

Modern Dental Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
83
Outperform
€10.68B17.5823.40%2.89%6.51%4.85%
74
Outperform
€5.18B10.9217.42%3.73%6.87%18.37%
74
Outperform
€2.12B13.753.76%6.98%21.39%-0.57%
74
Outperform
HK$22.89B39.6124.57%0.68%13.58%24.59%
70
Neutral
HK$5.36B25.9210.31%0.98%14.06%3.02%
63
Neutral
HK$11.48B240.00
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3600
Modern Dental Group Limited
5.34
1.78
50.17%
HK:9997
Kangji Medical Holdings Limited
9.05
3.23
55.58%
HK:1358
PW Medtech Group Ltd.
1.39
0.42
43.60%
HK:1501
Shanghai Kindly Medical Instruments Co., Ltd. Class H
30.50
2.50
8.93%
HK:2276
Shanghai Conant Optical Co. Ltd. Class H
49.68
35.50
250.35%
HK:6699
Angelalign Technology Inc.
67.30
2.66
4.12%

Modern Dental Group Limited Corporate Events

Modern Dental Group Achieves Record Financial Performance Amidst Industry Challenges
Aug 28, 2025

Modern Dental Group Limited reported record revenues, net profit, and EBITDA for the first half of 2025, driven by multi-dimensional strategies and digitalization in the dental industry. Despite a challenging macro-economic environment, the company increased its revenue by 7.8% to HK$1,834,814,000, with significant growth attributed to organic expansion and the acquisition of Hexa Ceram, Thailand’s largest dental laboratory. The company’s strong financial performance, including a 34.7% increase in net profit, underscores its solid fundamentals and strategic positioning to capitalize on emerging opportunities.

The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.

Modern Dental Group Declares Interim Dividend for 2025
Aug 28, 2025

Modern Dental Group Limited has announced an interim ordinary dividend of HKD 0.107 per share for the six months ending June 30, 2025. This announcement reflects the company’s financial performance and commitment to returning value to its shareholders, with the payment scheduled for October 9, 2025, impacting stakeholders by providing a return on their investment.

The most recent analyst rating on (HK:3600) stock is a Buy with a HK$4.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.

Modern Dental Group Schedules Board Meeting for Interim Results
Aug 15, 2025

Modern Dental Group Limited has announced a board meeting scheduled for August 28, 2025, to review and approve the unaudited interim results for the first half of 2025. The meeting will also consider the declaration or payment of dividends, which could impact the company’s financial strategy and shareholder returns.

The most recent analyst rating on (HK:3600) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.

Modern Dental Group Projects Strong Profit Growth for 1H 2025
Aug 14, 2025

Modern Dental Group Limited announced a positive profit alert for the first half of 2025, with expected revenue growth between 4.3% and 8.7%, and a net profit increase between 30.1% and 37.6% compared to the same period in 2024. The growth is attributed to organic expansion, improved operational efficiency through digital solutions, favorable currency movements, and the strategic acquisition of Hexa Ceram, enhancing the company’s market position and financial performance.

The most recent analyst rating on (HK:3600) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025